Berger Disease
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) (NCT03841448) | Alnylam Pharmaceuticals | 2019-09-30 |
Track Berger Disease automatically
Every clearance here is in the API, with alerts when new ones post.